BioSpace News Archive

BioMidwest

Lazurite’s ArthroFree™ Wireless Camera System for Minimally Invasive Surgery Receives FDA Market Clearance

Lazurite today announced that its ArthroFree™ System is now the first and only wireless camera system for minimally invasive surgery to receive U.S. Food and Drug Administration (FDA) market clearance.

March 24, 2022
·
6 min read
Global Orphan Drug Market Clinical Development Patent Report 2028

In recent times, the pharmaceutical sector is growing with high pace towards transformation. With the advent of enhanced technologies and innovative devices, the industry is reshaping the paradigm of treatments.

March 24, 2022
·
3 min read
Business

Valneva Reports Full Year 2021 Results and Provides Corporate Updates

Saint-Herblain, March24, 2022 – Valneva SE, a specialty vaccine company, reported its audited consolidated financial results for the year ending December 31, 2021 and provided corporate updates.

March 24, 2022
·
17 min read
Policy

Relief Receives Trademark Registration for RLF-100(R) From the U.S. Patent and Trademark Office

RELIEF THERAPEUTICS Holding SA announced that, on March 22, 2022, it received the certificate of registration for a trademark for RLF-100, from the United States Patent and Trademark Office.

March 24, 2022
·
4 min read
Business

Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage of its Evolution

Sosei Group Corporation confirms that a series of Executive Management changes have been approved at the Company’s 32nd Shareholders’ Meeting today and are effective immediately.

March 24, 2022
·
8 min read
Business

Innate Pharma Reports Full Year 2021 Financial Results and Business Update

Innate Pharma SA reported its consolidated financial results for the year ending December 31, 2021.

March 24, 2022
·
40 min read
Pharm Country

Geneos Therapeutics Secures $17 Million in Series A2 Financing to Advance Personalized Cancer Immunotherapy Platform

Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of tumor neoantigen targeted personalized immunotherapies, announced that it has secured $17 million in Series A2 financing.

March 24, 2022
·
5 min read
Orion is planning to refocus its R&D – in the future focus would be on cancer and pain

Orion is planning to change and refocus the strategy of its R&D function. The company would invest in the research and development of new proprietary drugs in two therapy areas, cancer and pain.

March 24, 2022
·
6 min read
Biotech Bay

NanoTemper Technologies Launches Spectral Shift, a Breakthrough Technology That Changes the Game for Affinity-Based Screenings

NanoTemper’s Dianthus instrument includes breakthrough Spectral Shift technology to handle the most challenging affinity-based screenings in drug discovery.

March 24, 2022
·
2 min read
The Biomarkers bio-ADM and DPP3 Complement Post-Cardiac Surgery Diagnostics to Early Detect Organ Failure

The diagnostic company SphingoTec GmbH announces new evidence supporting the use of innovative biomarkers in the early identification of organ dysfunction and risk stratification of cardiac surgery patients.

March 24, 2022
·
3 min read